On 18 January 2022, the Pan-Canadian Formulary Advisory Panel presented an information session with its recommendations for the development of a framework for a potential pan-Canadian prescription drug list, or formulary.

The Pan-Canadian Formulary Advisory Panel was established by the Canadian Agency for Drugs and Technologies in Health at the request of Health Canada. The information session focused on:

  • the principles for developing a pan-Canadian formulary framework;
  • a sample list of prescribed drugs to include on the potential formulary as a test case; and
  • criteria and processes for expanding the sample list.

For further information on this topic please contact Urszula Wojtyra at Smart & Biggar by telephone (+1 416 593 5514) or email ([email protected]). The Smart & Biggar website can be accessed at www.smartbiggar.ca.